Tissue Transglutaminase Contributes to the Pathogenesis of Preeclampsia and Stabilizes Placental Angiotensin Receptor Type 1 by Ubiquitination-Preventing Isopeptide Modification-Reference-Cited by-同舟云学术

Tissue Transglutaminase Contributes to the Pathogenesis of Preeclampsia and Stabilizes Placental Angiotensin Receptor Type 1 by Ubiquitination-Preventing Isopeptide Modification

Published:2014-02 Issue:2 Volume:63 Page:353-361
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Liu Chen¹,Wang Wei¹,Parchim Nicholas¹,Irani Roxanna A.¹,Blackwell Sean C.¹,Sibai Baha¹,Jin Jianping¹,Kellems Rodney E.¹,Xia Yang¹

Affiliation:

1. From the Department of Biochemistry and Molecular Biology (C.L., W.W., N.P., R.A.I., J.J, R.E.K., Y.X.) and Department of Obstetrics, Gynecology, and Reproductive Sciences (S.C.B., B.S.), The University of Texas Health Science Center at Houston; and The University of Texas Graduate School of Biomedical Sciences at Houston (N.P., J.J., R.E.K., Y.X.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference44 articles.

1. Pathogenesis and genetics of pre-eclampsia

2. Latest Advances in Understanding Preeclampsia

3. Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia

4. Hypertension Produced by Reductions in Uterine Perfusion in the Pregnant Rat

5. Hypertension Produced by Reductions in Uterine Perfusion in the Pregnant Rat

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models;Stem Cell Research & Therapy;2024-05-12

2. Tissue transglutaminase: a multifunctional and multisite regulator in health and disease;Physiological Reviews;2024-01-01

3. Transglutaminases from animals;Transglutaminase;2024

4. Transglutaminases in cardiovascular health and disease;Transglutaminase;2024

5. AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability;Brain, Behavior, and Immunity;2023-02